246
staff
Megan Ranney, MD
Megan L. Ranney, MD, is the dean of the Yale School of Public Health and C-EA Winslow Professor o
f Public Health at Yale University.
+ Read More
staff
Michelle Longmire
Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for diseas
e as the founder and Chief Executive Officer of Medable. A Stanford-trained physician-scientist, Dr.
+ Read More
staff
Debi Brooks
Deborah W. Brooks is Chief Executive Officer (CEO) and Co-Founder of The Michael J. Fox Foundatio
n for Parkinson's Research (MJFF). Ms. Brooks launched MJFF with Michael J. Fox in 2000 and served as founding CEO until 2007.
+ Read More
staff
Christopher Austin
Christopher Austin, MD, is a CEO-partner at Flagship Pioneering in Cambridge, MA, and CEO of Vesa
lius Therapeutics, one of Flagship’s franchise companies that is commercializing a platform to systematically develop treatments for common diseases.
+ Read More
person
Megan van der Horst, PhD
Megan van der Horst, PhD, was an associate from 2021 to 2022 at the Milken Institute Center for S
trategic Philanthropy. She worked on the Center’s biomedical team, where she conducted research into ALS scientific and funding landscapes.
+ Read More
person
Justin Sun
report
Food and Agriculture in Asia: Investing in Resilience, Health, and Sustainability
As the world reels from multiple crises in rapid succession, the opportunities to set food systems
on a more sustainable and equitable path have never been more favorable, and in turn, the importance of multi-stakeholder convenings cannot be understated
+ Read More
report
Shared Responsibility: The Future of Green Financing
As the demand for green financing gains momentum, so too does the demand for complementary and prox
y industries, standards, and regulatory frameworks.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
report
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that
has challenged patients, their families, and the medical community for generations.
+ Read More
report
Best Practices of Sovereign Wealth Funds: The Case for The Philippines
Many nations create sovereign wealth funds (SWFs) to invest surplus assets in a diversified portfol
io approach to achieve national policy goals, hedge against economic risk, and benefit successive generations.
+ Read More
report
Our Shared Responsibility: Technologies Accelerating the Path to Green Financing
In a private roundtable at the 2022 Singapore Fintech Festival, leading technologists, chief sustai
nability officers, large investors, and financial regulators gathered for off-the-record dis
+ Read More